Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IceCure Medical (ICCM) Shares Outstanding (Diluted Average) (2020 - 2026)

IceCure Medical has reported Shares Outstanding (Diluted Average) over the past 7 years, most recently at $73.6 million for Q1 2026.

  • For Q1 2026, Shares Outstanding (Diluted Average) rose 27.64% year-over-year to $73.6 million; the TTM value through Mar 2026 reached $73.6 million, up 27.64%, while the annual FY2025 figure was $63.6 million, 24.97% up from the prior year.
  • Shares Outstanding (Diluted Average) was $73.6 million for Q1 2026 at IceCure Medical, up from $63.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $73.6 million in Q1 2026 and bottomed at $37.0 million in Q4 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $54.3 million (2024), against an average of $54.7 million.
  • Year-over-year, Shares Outstanding (Diluted Average) rose 29.66% in 2022 and then increased 11.48% in 2024.
  • Over 5 years, Shares Outstanding (Diluted Average) stood at $37.0 million in 2022, then grew by 23.29% to $45.6 million in 2023, then increased by 11.48% to $50.9 million in 2024, then rose by 24.97% to $63.6 million in 2025, then rose by 15.72% to $73.6 million in 2026.
  • The last three reported values for Shares Outstanding (Diluted Average) were $73.6 million (Q1 2026), $63.6 million (Q4 2025), and $57.6 million (Q1 2025) per Business Quant data.